Related references
Note: Only part of the references are listed.REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
D. M. Weinreich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A Monoclonal Antibody for Malaria Prevention
M. R. Gaudinski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Functional human IgA targets a conserved site on malaria sporozoites
Joshua Tan et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Army Liposome Formulation (ALF) family of vaccine adjuvants
Carl R. Alving et al.
EXPERT REVIEW OF VACCINES (2020)
Antibody Feedback Limits the Expansion of B Cell Responses to Malaria Vaccination but Drives Diversification of the Humoral Response
Hayley A. McNamara et al.
CELL HOST & MICROBE (2020)
Antibody responses to the RTS,S/AS01E vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique
Lina Sanchez et al.
NPJ VACCINES (2020)
Mapping functional humoral correlates of protection against malaria challenge following RTS,S/AS01 vaccination
Todd J. Suscovich et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Induction and decay of functional complement-fixing antibodies by the RTS,S malariavaccine in children, and a negative impact of malaria exposure
Liriye Kurtovic et al.
BMC MEDICINE (2019)
Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies
Daniel G. W. Alanine et al.
CELL (2019)
Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/ASO1E malaria vaccine efficacy
Carlota Dobano et al.
NATURE COMMUNICATIONS (2019)
A Molecular Signature in Blood Reveals a Role for p53 in Regulating Malaria-Induced Inflammation
Tuan M. Tran et al.
IMMUNITY (2019)
Optimization of an in vivo model to study immunity to Plasmodium falciparum pre-erythrocytic stages
Yevel Flores-Garcia et al.
MALARIA JOURNAL (2019)
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
Sabue Mulangu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Antibodies against Plasmodium falciparum malaria at the molecular level
Jean-Philippe Julien et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection
Stephen W. Scally et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children
Liriye Kurtovic et al.
BMC MEDICINE (2018)
Peek-Peak-Pique: Repeating Motifs of Subtle Variance Are Targets for Potent Malaria Antibodies
Stephen W. Scally et al.
IMMUNITY (2018)
Immunization of Malaria-Preexposed Volunteers With PfSPZ Vaccine Elicits Long-Lived IgM Invasion-Inhibitory and Complement-Fixing Antibodies
Isabelle Zenklusen et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein
Joshua Tan et al.
NATURE MEDICINE (2018)
A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite
Neville K. Kisalu et al.
NATURE MEDICINE (2018)
Antihomotypic affinity maturation improves human B cell responses against a repetitive epitope
Katharina Imkeller et al.
SCIENCE (2018)
RTS, S/AS01 malaria vaccine mismatch observed among Plasmodium falciparum isolates from southern and central Africa and globally
Julia C. Pringle et al.
SCIENTIFIC REPORTS (2018)
Combination therapy with anti-HIV-1 antibodies maintains viral suppression
Pilar Mendoza et al.
NATURE (2018)
Malaria prevention: from immunological concepts to effective vaccines and protective antibodies
Ian A. Cockburn et al.
NATURE IMMUNOLOGY (2018)
Antibody-Mediated Protection against Plasmodium Sporozoites Begins at the Dermal Inoculation Site
Yevel Flores-Garcia et al.
MBIO (2018)
Cytotoxic anti-circumsporozoite antibodies target malaria sporozoites in the host skin
Eduardo Aliprandini et al.
NATURE MICROBIOLOGY (2018)
Cryo-EM structure of P. falciparum circumsporozoite protein with a vaccine-elicited antibody is stabilized by somatically mutated inter-Fab contacts
David Oyen et al.
SCIENCE ADVANCES (2018)
Force Spectroscopy of the Plasmodium falciparum Vaccine Candidate Circumsporozoite Protein Suggests a Mechanically Pliable Repeat Region
Aditya Prasad Patra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Natural Parasite Exposure Induces Protective Human Anti-Malarial Antibodies
Gianna Triller et al.
IMMUNITY (2017)
A method for the isolation and characterization of functional murine monoclonal antibodies by single B cell cloning
Sara Carbonetti et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2017)
Structural basis for antibody recognition of the NANP repeats in Plasmodium falciparum circumsporozoite protein
David Oyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection
Kirsten E. Lyke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
Katharine A. Collins et al.
SCIENTIFIC REPORTS (2017)
Delayed fractional dose regimen of the RTS, S/AS01 malaria vaccine candidate enhances an IgG4 response that inhibits serum opsonophagocytosis
Sidhartha Chaudhury et al.
SCIENTIFIC REPORTS (2017)
The biological function of antibodies induced by the RTS,S/AS01 malaria vaccine candidate is determined by their fine specificity
Sidhartha Chaudhury et al.
MALARIA JOURNAL (2016)
Reversible Conformational Change in the Plasmodium falciparum Circumsporozoite Protein Masks Its Adhesion Domains
Raul Herrera et al.
INFECTION AND IMMUNITY (2015)
Proteolytic Cleavage of the Plasmodium falciparum Circumsporozoite Protein Is a Target of Protective Antibodies
Diego A. Espinosa et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial
H. Tinto et al.
LANCET (2015)
Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
Michael T. White et al.
LANCET INFECTIOUS DISEASES (2015)
Genetic Diversity and Protective Efficacy of the RTS, S/AS01 Malaria Vaccine
D. E. Neafsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Complementary and synergistic activities of anti-V3, CD4bs and CD4i antibodies derived from a single individual can cover a wide range of HIV-1 strains
Kristel Paola Ramirez Valdez et al.
VIROLOGY (2015)
Improved expression of secretory and trimeric proteins in mammalian cells via the introduction of a new trimer motif and a mutant of the tPA signal sequence
Jia-Ye Wang et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2011)
The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian host
Alida Coppi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
Selidji Todagbe Agnandji et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Structure of the Plasmodium falciparum Circumsporozoite Protein, a Leading Malaria Vaccine Candidate
Matthew L. Plassmeyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data
Vasee S. Moorthy et al.
MALARIA JOURNAL (2009)
The Plasmodium circumsporozoite protein is proteolytically processed during cell invasion
A Coppi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites
PD Kwong et al.
NATURE (2002)
High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells
Y Durocher et al.
NUCLEIC ACIDS RESEARCH (2002)
Share Paper
